ARCTURUS THERAPEUTICS HOLDIN
ARCTNASDAQ🏆 #3172 by market capEarnings Nov 5US Equity
$12.15▲ $0.08 (+0.66%)
🌅 Pre-market$11.95▼ 1.65%Regular close · extended-hours price shownTrack ARCT
Get earnings, price moves & breaking news on Telegram
24h▲ 0.7%
7d▲ 23.6%
14d▲ 17.4%
30d▼ 11.1%
ytd▲ 98.9%
1y▲ 26.0%
🏦Market Cap
$345M
Small Cap
📈Revenue Growth (YoY)
-51.4%
Declining
📊Gross Margin
83.2%
High
💵FCF Margin
-306.9%
Thin
⚖️P/S Ratio
14.4x
Expensive
Otter Score
52
Fair
ARCTURUS THERAPEUTICS HOLDIN
ARCTAnalyst Ratings
Price
$12.15
Total
21
Raised
3
Lowered
7
Avg PT
$30.50
H / L
$41 / $20
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Leerink Partners | Reiterated | Outperform | 2026-10-09 | $54.00 | +344.40% |
Citigroup | Upgraded | Neutral → Buy | 2026-09-24 | — | — |
BTIG | Reiterated | Buy | 2026-09-24 | $20.00 | +64.60% |
B. Riley Securities | Upgraded | Neutral → Buy | 2026-03-18 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-03-04 | $25.00 | +105.80% |
HC Wainwright & Co. | Reiterated | Neutral | 2025-11-11 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2025-10-23 | — | — |
Wells Fargo | Reiterated | Overweight | 2025-10-23 | — | — |
Scotiabank | Reiterated | Sector Outperform | 2025-07-02 | $32.00 | +163.40% |
Canaccord Genuity | Reiterated | Buy | 2025-05-13 | $74.00 | +509.10% |
Cantor Fitzgerald | Reiterated | Overweight | 2025-03-07 | — | — |
Goldman Sachs | Reiterated | Sell | 2022-11-10 | $14.00 | +15.20% |
Baird | Downgraded | Neutral → Underperform | 2022-11-10 | — | — |
Barclays | Upgraded | Underweight → Equal Weight | 2022-11-02 | $25.00 | +105.80% |
Raymond James | Downgraded | Market Perform → Underperform | 2022-08-10 | — | — |
B. Riley FBR | Downgraded | Buy → Neutral | 2021-01-15 | — | — |
Roth Capital | Downgraded | Buy → Sell | 2020-12-23 | $41.00 | +237.40% |
WBB Securities | Reiterated | Buy | 2020-11-25 | — | — |
Miller Tabak | Downgraded | Strong Buy → Buy | 2020-11-25 | — | — |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2020-11-25 | — | — |
H.C. Wainwright | Reiterated | Buy | 2020-11-25 | $60.00 | +393.80% |
Institution
Leerink Partners
Reiterated · Outperform · 2026-10-09
$54.00
+344.40%
Citigroup
Upgraded · Neutral → Buy · 2026-09-24
—
—
BTIG
Reiterated · Buy · 2026-09-24
$20.00
+64.60%
B. Riley Securities
Upgraded · Neutral → Buy · 2026-03-18
—
—
Piper Sandler
Reiterated · Overweight · 2026-03-04
$25.00
+105.80%
HC Wainwright & Co.
Reiterated · Neutral · 2025-11-11
—
—
Guggenheim
Downgraded · Buy → Neutral · 2025-10-23
—
—
Wells Fargo
Reiterated · Overweight · 2025-10-23
—
—
Scotiabank
Reiterated · Sector Outperform · 2025-07-02
$32.00
+163.40%
Canaccord Genuity
Reiterated · Buy · 2025-05-13
$74.00
+509.10%
Cantor Fitzgerald
Reiterated · Overweight · 2025-03-07
—
—
Goldman Sachs
Reiterated · Sell · 2022-11-10
$14.00
+15.20%
Baird
Downgraded · Neutral → Underperform · 2022-11-10
—
—
Barclays
Upgraded · Underweight → Equal Weight · 2022-11-02
$25.00
+105.80%
Raymond James
Downgraded · Market Perform → Underperform · 2022-08-10
—
—
B. Riley FBR
Downgraded · Buy → Neutral · 2021-01-15
—
—
Roth Capital
Downgraded · Buy → Sell · 2020-12-23
$41.00
+237.40%
WBB Securities
Reiterated · Buy · 2020-11-25
—
—
Miller Tabak
Downgraded · Strong Buy → Buy · 2020-11-25
—
—
Ladenburg Thalmann
Downgraded · Buy → Neutral · 2020-11-25
—
—
H.C. Wainwright
Reiterated · Buy · 2020-11-25
$60.00
+393.80%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space